Maureen Horan v. Dilbet Inc, 17-2243

Background

In July 2010 Maureen Horan ate three raw clams at the Windrift restaurant and later developed Vibrio vulnificus sepsis and necrotizing fasciitis, requiring major amputations and surgeries.
Months later testing revealed Horan had hemochromatosis, a condition predisposing her to invasive Vibrio infection.
A county health inspector conducted an initial routine inspection (no raw-bar problems noted), then, after learning of Horan’s illness, returned and identified multiple sanitation concerns at the Windrift’s raw bar.
Horan sued under the New Jersey Products Liability Act (NJPLA), alleging the Windrift’s unsanitary handling increased the risk of an infectious Vibrio dose in the clams (defective product claim).
District Court initially denied summary judgment, finding Horan might show the clams were delivered with non-infective Vibrio levels and that Windrift’s conduct could have increased risk; later, on the eve of trial, the court excluded plaintiff’s expert (Dr. Oliver) as speculative and granted summary judgment for the Windrift.
Dr. Oliver conceded he could not determine whether clams contained infective levels at delivery and described some opinions as speculative; courts and experts agree Vibrio is naturally occurring and not harmful to most consumers unless infective dosage exists.

Issues

Issue	Horan's Argument	Windrift's Argument	Held
Whether clams containing Vibrio are per se defective under the NJPLA	Vibrio-contaminated clams should be treated like other contaminated foods and liability may be based on increased risk from defendant’s handling	Vibrio is naturally occurring and harmless to most consumers; mere presence does not establish a defect	Court held clams with Vibrio are not per se defective (plaintiff waived challenging this on appeal)
What causation standard applies under NJPLA: increased-risk vs. but-for showing clams were non-infective at delivery	Causation can be shown by proving Windrift’s handling increased risk of harm (increased-risk standard suffices)	Plaintiff must show Windrift created a defect (i.e., clams arrived non-infective and Windrift’s handling produced infective dose)	Court required plaintiff to prove the Windrift created the defect by showing clams were non-infective at delivery; without that showing causation cannot be established
Admissibility of plaintiff’s expert testimony under Rule 702	Expert could identify factors affecting Vibrio levels and support a jury finding that clams were non-infective at delivery	Expert’s opinions were speculative and lacked sufficient foundation to link delivery conditions to infective dose	Court excluded Dr. Oliver’s testimony as speculative and unsupported, and affirmed exclusion as not an abuse of discretion
Appropriateness of summary judgment after expert exclusion	Exclusion left plaintiff without competent evidence to show defect or causation, so summary judgment was improper	Exclusion eliminated plaintiff’s proof; summary judgment appropriate because no admissible evidence that clams were non-infective at delivery	Court affirmed summary judgment for Windrift because plaintiff lacked admissible evidence to prove defect/causation

Key Cases Cited

Myrlak v. Port Auth. of New York & New Jersey, 723 A.2d 45 (N.J. 1999) (elements of NJPLA product-defect claim).
Simeon v. Doe, 618 So. 2d 848 (La. 1993) (raw oysters with Vibrio not unreasonably dangerous to ordinary consumers).
Woeste v. Washington Platform Saloon & Rest., 836 N.E.2d 52 (Ohio Ct. App. 2005) (Vibrio naturally occurring; not adulteration absent injurious levels).
In re Fosamax (Alendronate Sodium) Prod. Liab. Litig., 852 F.3d 268 (3d Cir. 2017) (summary-judgment principles regarding admissible facts needed for jury to apply law).
In re Zoloft (Sertraline Hydrochloride) Prod. Liab. Litig., 858 F.3d 787 (3d Cir. 2017) (standard of review on exclusion of expert testimony under Rule 702).
DiFiore v. CSL Behring, LLC, 879 F.3d 71 (3d Cir. 2018) (plenary review of legal questions on summary judgment).